Calcitriol inhibits the growth of MHCC97 heptocellular cell lines by down-modulating c-met and ERK expressions

Liver International

Volumn 27, Issue 5, 2007, Pages 700-707

  Wu, Fu Sheng ^a   Zheng, Shu Sen ^a   Wu, Ling Jiao ^a   Teng, Li Song ^a   Ma, Zhi Min ^a   Zhao, Wen He ^a   Wu, Wei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C met; Calcitriol 1,25 dihydroxyvitamin D3; Extra cellular signal regulated kinase; Hepatocellular carcinoma; Hepatocyte growth factor; MHCC97cell line

Indexed keywords

CALCITRIOL; IODINATED POPPYSEED OIL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; CALCITRIOL; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, CALCITRIOL; VITAMINS;

EID: 34547103240     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01487.x     Document Type: Article

References (34)

1. Huang YH, Wu JC, Chen CH, et al. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int 2005; 25: 236-41.
2. Gao CF, Vande Woude GF. HGF/SF-Met signaling in tumor progression. Cell Res 2005; 15 (1): 49-51.
3. Lee HS, Huang AM, Huang GT, et al. Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells. J Biomed Sci 1998; 5: 180-4.
4. Potempa S, Ridley AJ. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherent junction disassembly. Mol Biol Cell 1998; 9: 2185-200.
5. Sergeant N, Lyon M, Rudland PS, Fernig DG, Delehedde M. Stimulation of DNA synthesis and cell proliferation of human mammary myoepithelial-like cells by hepatocyte growth factor/scatter factor depends on heparan sulfate proteoglycans and sustained phosphorylation of mitogen-activated protein kinases p42/44. J Biol Chem 2000; 275: 17094-9.
6. van den Bemd GJ, Pols HA, van Leeuwen JP. Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs. Curr Pharm Des 2000; 6: 717-32.
7. Beer TM, Myrthue A. Calcitriol in cancer treatment: From the lab to the clinic. Mol Cancer Therapeut 2004; 3: 373-81.
8. Chattopadhyay N, MacLeod RJ, Tfelt-Hansen J, Brown EM. 1alpha, 25(OH)2-vitamin D3 inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells. Am J Physiol Endocrinol Metab 2003; 284: E219-27.
9. Inaba M, Koyama H, Hino M, et al. Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. Blood 1993; 82: 53-9.
10. Tian J, Tang ZY, Ye SL, et al. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 1999; 81: 814-21.
11. Li Y, Tang ZY, Ye SL, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7: 630-6.
12. Pourgholami MH, Akhter J, Lu Y, Morris DL. In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3. Cancer Lett 2000; 151: 97-102.
13. Caputo A, Pourgholami MH, Akhter J, Morris DL. 1,25-Dihydroxyvitamin D3 induced cell cycle arrest in the human primary liver cancer cell line HepG2. Hepatol Res 2003; 26: 34-9.
14. Sahpazidou D, Stravoravdi P, Toliou T, et al. Significant experimental decrease of the hepatocellular carcinoma incidence in C3H/Sy mice after long-term administration of EB1089, a vitamin D analogue. Oncol Res 2003; 13: 261-8.
15. Miyaguchi S, Watanabe T. The role of vitamin D3 receptor mRNA in the proliferation of hepatocellular carcinoma. Hepatogastroenterology 2000; 47: 468-72.
16. Durand-Fontanier S, Simon A, Duroux JL, Descottes B, Delage C. Lipiodol ultra-fluid: An antitumor agent-in vitro study. Anticancer Res 1999; 19: 4357-61.
17. Pourgholami MH, Akhter J, Finlay IG, Morris DL. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2. Anticancer Res 2000; 20: 723-7.
18. Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs-a brief overview. Mol Cell Biochem 2003; 253: 247-54.
19. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277: F157-75.
20. Evans SR, Houghton AM, Schumaker L, et al. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines. J Surg Res 1996; 61: 127-33.
21. Wu F, Wu L, Zheng S, et al. The clinical value of hepatocyte growth factor and its receptor-c-met for liver cancer patients with hepatectomy. Dig Liver Dis 2006; 38: 490-7.
22. Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 2001; 153: 1023-34.
23. Guirouilh J, Castroviejo M, Balabaud C, Desmouliere A, Rosenbaum J. Hepatocarcinoma cells stimulate hepatocyte growth factor secretion in human liver myofibroblasts. Int J Oncol 2000; 17: 777-81.
24. Horiguchi N, Takayama H, Toyoda M, et al. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 2002; 21: 1791-9.
25. Yong He, Jun Zhou, Ke-Feng Dou, Yong Chen, Qing-Guo Yan, Hai-Min Li. Autocrine expression of hepatocyte growth factor and its cytoprotective effect on hepatocyte poisoning. World J Gastroenterol 2004; 10: 2827-30.
26. Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact 2006; 160: 123-33.
27. Kermorgant S, Zicha D, Parker PJ. PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J 2004; 23: 3721-34.
28. Chen Z, Gibson TB, Robinson F, et al. MAP kinases. Chem Rev 2001; 101: 2449-76.
29. Kohno M, Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann Med 2006; 38: 200-11.
30. Tsuboi Y, Ichida T, Sugitani S, et al. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma. Liver Int 2004; 24: 432-6.
31. Osada S, Kanematsu M, Imai H, et al. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma. J Am Coll Surg 2005; 201: 405-11.
32. Bernardi RJ, Trump DL, Yu WD, McGuire TF, Hershberger PA, Johnson CS. Combination of 1α,25-Dihydroxyvitamin D3 with Dexamethasone enhances cell cycle arrest and apoptosis: Role of nuclear receptor cross-talk and erk/akt signaling. Clin Cancer Res 2001; 7: 4164-73.
33. McGuire TF, Trump DL, Johnson CS. Vitamin D3 induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem 2001; 276: 26365-73.
34. Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAPkinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 2003; 101: 2454-60.